Molecular HPV testing is now the accepted modality for primary cervical screening. The requirement for optimal triage tests which can separate clinically significant from benign HPV infect ion is thus extremely timely.
|Publication status||Published - Dec 2018|
|Event||EUROGIN 2018 - From control to elimination of HPV induced cancers - Lisbon, Portugal|
Duration: 2 Dec 2018 → 5 Dec 2018
|Conference||EUROGIN 2018 - From control to elimination of HPV induced cancers|
|Abbreviated title||Eurogin 2018|
|Period||2/12/18 → 5/12/18|